2023 Year In Review
2023
Another year of backing exceptional leaders
2023 Committed Capital
With $831 million in annual debt and equity commitments and $642 million in annual fundings, we are focused on funding growth stories.
16+ Years
A long history of investing in visionaries
$1.3 Billion
Assets Under management*
*As of September 30, 2023
We are proud of the companies we’ve partnered with and are excited to support more world-changing technologies into the future.
Strong Shareholder Returns
12 Consecutive Quarters of increase in Dividends
Diversification across asset size, product type, industry and geography
NASDAQ: TRIN
17.6%
Return on Average Equity*
*As of September 30, 2023, Annualaized
24%
Increase in NAV (annual)*
Solid Dividend Growth
14%
Annualized Dividend Yield*
*As of December 31, 2023
$0.50
Regular dividend declared in 4Q23
Represents a 2% increase over the prior quarter
Select Portfolio News
This year has been a remarkable one for our portfolio companies, as they continue to break new ground and achieve significant milestones. Here are a few select highlights.
Axiom Space, Prada Join Forces on Tech, Design for NASA’s Next-Gen Lunar Spacesuits
In the first groundbreaking partnership between an Italian luxury fashion house and a commercial space company, Axiom Space, industry leader and architect of the world’s first commercial space station, announces a collaboration with Prada on NASA's lunar spacesuits for the Artemis III mission.
$452M canned drink factories coming to Fort Worth sites from DrinkPak
California-based DrinkPak LLC is moving ahead with North Texas expansion, a project that could bring 1,000 jobs and a $452 million investment to Fort Worth. The expansion represents a significant win for the city, which continues to make strides in attracting manufacturing.
Revelle Aesthetics Receives First International Clearance in Australia for its Avéli® Cellulite Device
Revelle Aesthetics, a VC-backed Silicon Valley FemTech company, today announced that Avéli®, its US FDA-cleared device for long-term reduction in the appearance of cellulite, has received its first international clearance in Australia, one of the largest market opportunities for cellulite outside of the U.S.
Awards & Recognition
2023 | Inc.’s Founder
Friendly
This recognition continues to affirm our commitment to the incredible founders and innovators in our ecosystem.
2023 | ABF Innovative Company
Our team continues to evolve and innovate to address the capital needs of both prospective and current portfolio companies.
2023 | Arizona’s top companies to work for
Trinity Capital proudly secures its place as one of Arizona’s Top Companies to Work for in 2023 for the second consecutive year, a testament to our amazing work culture.
